BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 69018)

  • 21. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
    Ramasamy R; Joseph B; Whittall T
    Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. A longitudinal study employing direct buffy coat migration inhibition assays.
    Lisak RP; Zweiman B; Waters D; Korpowski H; Pleasure DE
    Neurology; 1978 Aug; 28(8):798-803. PubMed ID: 567297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis.
    Sheremata W; Younge B; Eylar EH
    Neurology; 1977 Jun; 27(6):557-60. PubMed ID: 559264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
    Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
    Cross AH; Tuohy VK; Raine CS
    Cell Immunol; 1993 Feb; 146(2):261-9. PubMed ID: 7513616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.
    Sakai K; Sinha AA; Mitchell DJ; Zamvil SS; Rothbard JB; McDevitt HO; Steinman L
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8608-12. PubMed ID: 2460872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis.
    Heber-Katz E
    Ann N Y Acad Sci; 1995 Jul; 756():283-93. PubMed ID: 7544078
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E; Stickl H
    Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
    Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP
    Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis.
    Møller-Larsen A; Haahr S; Hansen HJ
    J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.
    Martin R; Howell MD; Jaraquemada D; Flerlage M; Richert J; Brostoff S; Long EO; McFarlin DE; McFarland HF
    J Exp Med; 1991 Jan; 173(1):19-24. PubMed ID: 1702137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.